Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04487210
Recruitment Status : Completed
First Posted : July 27, 2020
Last Update Posted : January 31, 2022
Information provided by (Responsible Party):
Medigen Vaccine Biologics Corp.